GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
DHS announces $1 billion in FEMA funding for Georgia recovery from Hurricane Helene, Tropical Storm Debby and COVID-19 efforts, even as Trump administration looks to revamp agency....
A bank robber using stickup notes to scare tellers into handing over cash in at least two Flagstar locations in a 48-hour spree has been arrested, police said. ...
Judge Paula Xinis of the U.S District court in Maryland has ruled in favor of Salvadoran illegal alien Kilmar Abrego Garcia....
